Revolutionizing sarcoma therapy

The focus of cancer therapy is moving towards precision medicine. However, very few efficacious therapies are available for sarcomas. There is a clear unmet need for new therapies for the broad and heterogeneous group of soft tissue sarcomas. We are committed to delivering innovative therapeutic options for patients who have no specific therapies or have failed all currently available options.


Upcoming events and news

Sartarin rahoituskierros on auki!

Sartar on avannut rahoituskierroksen yhdessä Springvestin kanssa! Rahoituskierros on auki lokakuun loppuun asti. Osoitteesta löytyy lisätietoa kampanjasta!